PROSPECTIVE NON-RANDOMIZED STUDY WITH CHEMOTHERAPY FOR RELAPSED OR REFRACTORY HIV-RELATED NON-HODGKIN'S LYMPHOMA: VMP REGIMEN FOR RELAPSED PATIENTS, CDE REGIMEN FOR REFRACTORY PATIENTS

NCT00002905 Phase 2 UNKNOWN

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating patients with HIV-related non-Hodgkin's lymphoma that has relapsed or has not responded to chemotherapy.

Details

Lead sponsor	Centro di Riferimento Oncologico - Aviano
Phase	Phase 2
Status	UNKNOWN
Enrolment	20
Start date	1995-06

Conditions

• Lymphoma

Interventions

• cyclophosphamide
• didanosine
• doxorubicin hydrochloride
• etoposide
• mitoxantrone hydrochloride
• prednimustine
• zidovudine

Countries

Italy